Title:
BIOLOGICAL CANCER TREATMENT COMPOSITION OF NATURAL KILLER CELL-DERIVED EXOSOMES WITH ENHANCED CYTOKINE ACTIVITY, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/058421
Kind Code:
A1
Abstract:
The present invention relates to a biological cancer treatment composition of natural killer cell-derived exosomes with enhanced cytokine activity, and a use thereof, and more specifically, to a cancer treatment composition containing natural killer cell (NK cell)-derived exosomes pretreated with cytokines, and a method for treating cancer, wherein the composition can be independently used for treating cancer or used for treating various cancers.
Inventors:
CHOI EUNPYO (KR)
PARK JONG-OH (KR)
CHOI YOU HEE (KR)
KIM IN YOUNG (KR)
KIM HO YONG (KR)
SONG HYEONG-WOO (KR)
PARK JONG-OH (KR)
CHOI YOU HEE (KR)
KIM IN YOUNG (KR)
KIM HO YONG (KR)
SONG HYEONG-WOO (KR)
Application Number:
PCT/KR2023/011223
Publication Date:
March 21, 2024
Filing Date:
August 01, 2023
Export Citation:
Assignee:
KOREA INST OF MEDICAL MICROROBOTICS (KR)
International Classes:
A61K35/17; A23L33/10; A61P35/00
Foreign References:
| EP3578201A1 | 2019-12-11 | |||
| KR20190101147A | 2019-08-30 | |||
| US20220119767A1 | 2022-04-21 | |||
| KR20210158265A | 2021-12-30 |
Other References:
ENOMOTO YUTAKA; LI PENG; JENKINS LISA M.; ANASTASAKIS DIMITRIOS; LYONS GAELYN C.; HAFNER MARKUS; LEONARD WARREN J.: "Cytokine-enhanced cytolytic activity of exosomes from NK Cells", CANCER GENE THERAPY, NATURE PUBLISHING GROUP US, NEW YORK, vol. 29, no. 6, 27 July 2021 (2021-07-27), New York, pages 734 - 749, XP037893753, ISSN: 0929-1903, DOI: 10.1038/s41417-021-00352-2
Attorney, Agent or Firm:
SRB IP & LAW FIRM (KR)
Download PDF:
Previous Patent: COMPLEX CLUTCH APPARATUS
Next Patent: CELL MONITORING CIRCUIT CAPABLE OF WIRELESS COMMUNICATION AND BATTERY MODULE PROVIDED WITH SAME
Next Patent: CELL MONITORING CIRCUIT CAPABLE OF WIRELESS COMMUNICATION AND BATTERY MODULE PROVIDED WITH SAME